Bruce N. Jacobs, Chief Financial Officer at Kymera Therapeutics, Inc. (KYMR), sold 19,700 shares at $54.32 ($1.1M) on 2021-12-03, disclosed to the SEC on 2021-12-03.
Open-market sale of $1.1M KYMR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.31 | 7,713 | $411K | 39.0% |
| 2 | $53.31 | 7,713 | $411K | 39.0% |
| 3 | $54.32 | 1,987 | $108K | 10.2% |
| 4 | $54.32 | 1,987 | $108K | 10.2% |
| 5 | $55.07 | 300 | $17K | 1.6% |
| Total | $53.54 avg | 19,700 |
| $1.1M |
| 100% |
| Filing → |
| KYMR | SELL | 2025-09-17 | $4.0M | — | Filing → |
| KYMR | SELL | 2025-03-03 | $389K | — | Filing → |
| KYMR | SELL | 2024-03-04 | $318K | — | Filing → |